Lifecare takes next steps in CGM implant development
July 2, 2025
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant.
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant.
Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.
New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. And the technology has the potential to further our understanding of other childhood diseases, according to a new study.
Mouse models are central to drug development, including treatments for neurological disorders, such as Parkinson’s disease. Such diseases often affect movement, and treatments may need to relieve symptoms such as tremors.
Scientists are increasingly finding that the gastrointestinal (GI) tract plays a vital role in our overall health. While its main functions center around digestion, the GI tract is also involved in the production of hormones, immune cells, and even neurotransmitters that can affect mood and brain function. As such, the GI tract is host to many different biomarkers that can be useful for identifying, monitoring, and treating disease—everything from short-chain fatty acids that are indicators of metabolic syndrome to cytokines that are biomarkers of inflammation.
Inne, a healthtech startup empowering women to understand their reproductive health, has ‘broken through decades of stagnation’ in women’s health and become what it says is the first new tech-enabled contraception to receive certification in the UK and Europe with its Minilab saliva test device.
A research team led by the University of the Basque Country has identified hundreds of molecular markers in saliva that could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases. Their results, published in npj Genomic Medicine, lay the foundation for the development of a powerful, non-invasive tool for early diagnosis and precision medicine.
Researchers at Chalmers University of Technology in Sweden and the University of Auckland in New Zealand have developed a groundbreaking bioelectric implant that restores movement in rats after injuries to the spinal cord. This breakthrough offers new hope for an effective treatment for humans suffering from loss of sensation and function due to spinal cord injury.
In order to understand the structure and functioning of the brain, neuroscientists need to study the complex, three-dimensional pathways and connections of nerve fibers. The intersection of multiple nerve fibers poses a particular challenge for neuroimaging.
Matthew Dean, Sales Engineer and Head of the Medical Business Unit at maxon, explores how Newrotex and maxon are developing an innovative approach to overcome the common challenges of traditional nerve repair.